Background: Previous research has produced inconsistent evidence of an association between housing stability and medication adherence among HIV-positive individuals in antiretroviral therapy.
INTRODUCTION
Poor adherence to antiretroviral therapy (ART) among HIV-positive patients has been associated with incomplete viral suppression, the emergence of drug-resistant variants, and progression to AIDS. 1 For economically vulnerable patients, efforts to adhere at high levels must compete with other survival needs, such as access to food and shelter. 2 Arguably, patients who experience homelessness may be particularly disadvantaged with respect to adherence, 3 facing a myriad of interrelated challenges including social isolation, substance use, mental illness, mistrust of the health care system, and inconsistent provider-patient relationships 4 -all of which affect access to services, health trajectories, and outcomes. 5 Over the past 15 years, a body of observational research has investigated the relationship between housing stability and ART adherence. The findings have been inconsistent. Some studies have found a positive association between housing stability and adherence, [6] [7] [8] [9] [10] whereas others have failed to reject the null hypothesis. [11] [12] [13] [14] [15] We set out to synthesize the evidence of these studies. Our aims were 4-fold: to evaluate the methodological rigor of the individual studies, analyze the heterogeneity of effects across studies, compute a quantitative estimate of the overall association, and provide a test of the null with more power than is provided by the separate studies alone. In short, the present meta-analysis is designed to examine and test as precisely as possible the relationship between housing stability and ART adherence among people living with HIV (PLWH).
MATERIALS AND METHODS

Eligibility Criteria
Eligibility for inclusion in the meta-analysis was limited to observational studies which met all the following criteria:
• the study population was adult PLWH who had a current ARV prescription and were engaged in ART;
• the study classified each patient's housing status into one of several categories ordered in terms of greater or lesser housing stability-eg, living on the streets, in a car, or in a shelter vs. living in a single-room occupancy hotel or motel; doubling up with different people (couch surfing) vs. residing in an own or shared apartment or house; • the study measured the level of antiretroviral medication adherence-ie, taking medication as prescribed-for each patient. The instruments for measuring adherence differed across studies; and • the results of the statistical test of association between housing stability and adherence level were reported in adequate detail-eg, point estimate and standard error.
To reduce confounding and measurement error, we took a conservative approach to study selection. We excluded studies in which the measure of housing stability was entirely subjective (eg, are you worried about having a place to stay?), merged with another construct (eg, foodhousing insecurity), or not time-specific (eg, were you ever homeless?). We also excluded studies in which the measure of adherence was merged with eligibility for therapy (eg, individuals who were eligible for but did not receive therapy were coded as not adherent) or discontinuation of therapy (eg, treatment discontinuation was coded as not adherent). Likewise, we excluded studies that limited their inquiry to a specific type of nonadherence (eg, sale or trade of ARV pills). Finally, to reduce heterogeneity due to international differences, we restricted our literature search to studies conducted in the United States, recognizing that the price for this restriction is a loss in generalizability. Our aim in this meta-analysis was a clear, direct, and focused test of the housing-adherence hypothesis.
Search Strategy
Systematic literature searches were conducted by a medical librarian, using PubMed (from 1947 through January 2016), Embase (from 1973 through January 2016), and Cochrane Central Register of Controlled Trials (from 1991 through January 2016), limiting the publication date between January 1, 2000, to January 31, 2016. For all databases, both controlled vocabulary and text word searches were performed. Manual searches of references from retrieved articles, major journals in the field, and gray literature (eg, abstracts and posters from scientific proceedings) were also performed to identify any additional relevant articles possibly missed by online indexes. We also contacted experts in the field to identify additional literature.
After the removal of 43 duplicates, the PubMedEmbase-Cochrane searches uncovered 164 articles. After screening the titles and abstracts, 85 articles were excluded, as they were not observational studies (eg, reviews, editorials, essays, and case reports) or studies conducted in the United States. The full text of 79 articles were collected and read. Of these, 61 did not analyze an association between housing and adherence among HIV+ individuals. Based on an evaluation by 2 of the authors, 10 studies did not meet the inclusion criteria, 8 met all the criteria, and an additional 2 studies were found through manual searches. Two of the authors conducted data extraction and quality assessment (QA) coding; there were no disagreements. A study selection flowchart ( Figure S1 ), data extraction form (Table S1) , and QA coding form (Table S2) Each domain was judged on a quality continuum with 2 levels (higher and lower), as follows. Longitudinal research designs were rated "higher" as were multisite designs. The approach to sample size considered the N in each housing comparison group; a study population with $50 persons in each housing group was rated "higher." The measure of housing stability in a study was rated "higher" if it used a clear and replicable operational definition for both comparators and did not use an undifferentiated residual category for one of the comparators (eg, all others were categorized as nonhomeless). A rating of "higher" for adherence required objective measurement (eg, medication event monitoring system caps, pharmacy refill data, and unannounced pill counts). We rated the adequacy of statistical controls "higher" if the study included a multivariate analysis that adjusted for other determinants of adherence (eg, food insecurity, depression, and substance abuse).
As most of the studies addressed several research questions, the housing-adherence question was not the main focus of each study. That was a limiting consideration in our choice of QA domains relative to the published methodological standards and guidelines for observational studies (eg, we did not include a domain for the prespecification of hypotheses). 16 Also, the cutoff criteria separating "higher" from "lower" quality were, to some extent, unavoidably arbitrary for the sample size, housing, and adherence domains. We chose stringent criteria to frame a decisive test of the null hypothesis in the QA metaregression analysis. In raising the bar, it should be emphasized that a "lower" rating on any 1 domain did not signify an overall weakness of a study. The QA relied on the full set of domains.
It is noteworthy that none of the studies scored "lower" or "higher" on every domain. Five of the 10 studies scored "higher" on 1 or 2 domains (Chen, Royal, Surratt, Waldrop-Valverde, and Delavega), and 5 studies scored higher on 3 or 4 domains (Berg, Kidder, Moss, Kalichman, and Johnson). Based on the sum of domains scored "higher," each study was assigned a value from 
Statistical Analysis
The outcome variable, adherence, was measured as a continuous variable in 4 of the primary articles (Berg, Moss, Surratt, and Delavega) and as a dichotomous variable in 6 articles (Johnson, Waldrop-Valverde, Kidder, Royal, Chen, and Kalichman). If a study reported multiple measures, we selected the result of the authors' primary adjusted model or the estimates with the greatest degree of adjustment for confounding. To meta-analyze studies that measured outcome in different ways, it was necessary to standardize the results of the studies to a uniform scale. 17 We followed the usual convention in meta-analysis and converted the effect size reported in each primary article to a standardized mean difference (SMD). 18 An SMD of 1.0 indicates that the mean values of 2 groups differ by 1 SD; an SMD of 0.5 indicates that the 2 groups' mean values differ by half an SD, and so on. For our specific area of inquiry, ie, estimating the association between housing stability and ART adherence, we considered the Cohen rule of thumb appropriate for interpreting the magnitude of the SMD effect size as follows: small = 0.20, medium = 0.50, and large = 0.80. 19 To estimate pooled effects and confidence intervals (95% CIs), we used a random-effects model because of the anticipated heterogeneity due to study design differences. We conducted a sensitivity analysis by omitting each study in sequence to test the robustness of association. We also estimated the effect of housing stability on adherence with a quality effects model that incorporated QA scores into the weighting scheme of the meta-analysis to give higher quality studies proportionately more weight in the overall effect size. Meta-regression were performed to further investigate the effects of study quality on effect size and to test for a secular trend in the data. Additional investigations into possible sources of heterogeneity were conducted with subgroup analysis. To assess statistical heterogeneity beyond chance, we used the x 2 and I 2 tests. Publication bias was assessed with a funnel plot and the Egger and Begg tests. Two-sided P values were presented, and significance was set at P , 0.05, except for the tests of homogeneity of effects where significance was set more conservatively at P , 0.10. We used MetaXL 5.2 for the quality effects model (Epigear International, Queensland, Australia). All other statistical analyses were performed using STATA 14.1 (StataCorp, College Station, TX). 
RESULTS
Association Between Housing Stability and ART Adherence
Ten studies, representing a total study population of 10,556 individuals, were included in the meta-analysis. Five studies showed a positive association, 5 showed no association, and none showed a negative association. Effect size heterogeneity was readily observable (Fig. 1) and statistically significant (I 2 = 64%, P , 0.01). Of those studies reporting a positive association, the effect sizes ranged from small (Johnson: SMD = 0.13, 95% CI: 0.01 to 0.25) to medium (Berg: SMD = 0.57, 95% CI: 0.18 to 0.97). In the meta-analysis, the overall effect was positive (SMD = 0.15, 95% CI: 0.02 to 0.29).
Sensitivity Analysis
To test the robustness of our findings, we performed a sensitivity analysis excluding each of the 10 studies in turn. This analysis showed that the pooled SMDs were similar in magnitude (Fig. 2) . No outliers were present. However, one study, Kidder, was found to be especially influential, in part because it had the largest N among the studies reporting a positive association between housing and adherence. Exclusion of this study slightly decreased the size and lower bound of the pooled estimate (SMD = 0.13, 95% CI: 20.02 to 0.29), indicating that the association between housing and adherence was robust at the P = 0.09 level. Exclusion of the Kidder study did not affect heterogeneity (I 2 = 63%, P , 0.01).
Subgroup, Meta-Regression, and Quality Effects Analysis
In a further investigation of heterogeneity, we conducted a QA subgroup analysis. Figure 3 displays the SMD and CI for each of the 10 studies grouped by numerical value on the QA scale along with the subgroup estimates. The test for differences across subgroups was not significant (P = 0.84). Similarly, the meta-regression analysis of the association between QA scale and SMDs revealed that the slope coefficient, although positive, was not significant (slope = 0.05, 95% CI: 20.11 to 0.21). We also estimated the overall effect using the quality effects statistical model. The model incorporates QA scores into the weighting scheme of the meta-analysis to give higher quality studies proportionately more weight in the overall effect size. 20, 21 The SMD was slightly larger in this analysis (SMD = 0.20, 95% CI: 0.01 to 0.39).
Subgroup analysis was also used to examine whether differences in the operational definition of housing stability would account for part of the heterogeneity in the size of effects on adherence. We divided the 10 studies into 4 categories according to the definitions used in the housing comparisons. The test for differences across subgroups was not significant (P = 0.13). The subgroup analysis forest plot ( Figure S3 ) is included in the Supplemental Digital Content, http://links.lww.com/QAI/A936.
Finally, we tested for a secular trend in the SMDs on the theory that patients' pill burden was substantial in the earlier years of our study period compared with the singletablet regimens more common in the later years, 22 and that the change would be reflected in a weaker association between housing and adherence over time. The metaregression estimate for this association was not significant (slope = 20.01, 95% CI: 20.05 to 0.03).
Publication Bias
Visual inspection of the funnel plot ( Figure S2 in the Supplemental Digital Content, http://links.lww.com/QAI/A936) did not show any obvious asymmetry. There was also no indication of publication bias as suggested by the Begg test (P = 0.66) and Egger test (P = 0.77). 
DISCUSSION
This is the first meta-analysis to examine the effects of housing stability on adherence to ART among PLWH. Our results suggest an increased risk of nonadherence in patients living on the streets or in transient housing compared with those in more stable arrangements, but the magnitude of the effect is small. Previous literature reviews, by contrast, have concluded that there is a strong association between housing and adherence, [23] [24] [25] but these conclusions did not rest on the rigorous statistical methods of meta-analysis. Our study fills that gap. In combining the primary studies into a single data set representing 10,556 individuals, we have computed a more precise estimate of the overall effect and conducted a more powerful test of the null, relative to less formal methods.
Our study has a number of important strengths and limitations. First, across the 10 observational studies, the dispersion of effect sizes was not overlarge, a finding which supports the logic of our strict eligibility criteria. The specific reasons for the heterogeneity remain unaccounted for. However, our investigations into possible sources of bias provide assurances that the individual studies are comparable-ie, address the same question with similar explanatory and outcome measures. Using the full complement of meta-analytic tools, we found no secular trend in the data, association of effect size with measurement approach to housing stability, or publication bias. Adjusting for the quality of the primary articles, the housing-adherence association was just slightly larger in the quality effects model. Second, most of the studies relied on purposive sampling methods. Participants were recruited from clinical sites, social service agencies, and targeted community outreach, using brochures, posters, media advertisements, staff contacts, referrals, clinic lists, and snowball methods. Other participants were obtained through ongoing cohort studies, Centers for Disease Control and Prevention and local public health surveillance systems, and jail detainee screenings (Table 1) . Although it is impossible to establish that the samples combined in the meta-analysis are statistically representative of the population of HIV-positive individuals engaged in ARV therapy in the United States, where good lists were unavailable, the primary studies chose sensible alternatives to probability sampling and, in the aggregate, they cover a broad spectrum of housing statuses.
Third, there is currently no "gold standard" of measurement for either housing stability or medication adherence. 26, 27 In each of the primary studies, the operational definition of housing stability had just 2 categories. Although the definitions had face validity, it is possible that with more highly developed instruments housing might have explained a larger percentage of the adherence variance and provided a more detailed understanding of the housing-adherence relationship. Regarding measuring ART adherence, 3 of the 10 primary studies used objective measures (microelectronic monitors and unannounced pill counts) and 7 relied exclusively on self-report instruments. The concurrent and predictive validity of self-report instruments have been well established. Still, field testing has shown that question wording and response options may not be consistently understood or applied by all respondents. 28 In addition, self-reported adherence measures are susceptible to recall and social desirability bias. 29 Fourth, our meta-analysis combined primary studies that differed in research design (eg, longitudinal and crosssectional designs, multisite and single site, large samples and small). Because variability in the study design is to be expected in any meta-analysis and is present to a greater degree when the primary studies are observational rather than randomized controlled trials, our results should be interpreted cautiously. Likewise, it is necessary to acknowledge the limitations of the primary literature and the need for more exacting research designs. We suggest that future research would benefit from appropriately powered, prospective cohort studies with longer follow-up periods. To closely map changes in housing and adherence over time, plans should include more fine-grained measures of housing status and objective measures of adherence.
Previous research has shown that at each stage in the continuum of HIV care, stable housing makes a difference, 23, 24 with the largest effects probably found in the earlier stages. 25 For those in care and in ARV therapy, the evidence of this study indicates that patients with stable housing tend to adhere better than those without, but the difference is small. The finding challenges the view that unstable housing is incompatible with adherence and questions the potential benefit of deferring ART initiation until the patient's housing circumstances are improved. The treatment guidelines of the U.S. Department of Health and Human Services 30 urge clinicians to address areas known to impair adherence-homelessness and unstable housing, among them-before (and after) the initiation of therapy. Given the results of the meta-analysis, the recommendation that ties ART readiness to housing should be reconsidered.
